Getting that hit: 3D database searching in drug discovery

Drug Discovery Today

Volumn 1, Issue 6, 1996, Pages 231-238

  Manallack, David T ^a  

^a Chiroscience Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001425443     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6446(96)88990-2     Document Type: Review

References (27)

1. Pearlman, R.S. (1993) in 3D QSAR in Drug Design: Theory. Methods and Applications (Kubinyi, H., ed.), pp. 41-70, ESCOM
2. Sadowskim, J. and Gasteiger, J. (1993) Chem. Rev. 93, 2567-2581
3. Mason, J.S. (1995) in Molecular Similarity in Drug Design (Dean, P.M., ed.), pp. 138-162, Blackie Academic and Professional
4. Good, A.C. and Mason, J.S. (1995) in Reviews in Computational Chemistry, Vol. 7 (Boyd, D.B. and Lipkowitz, K.B., eds), pp. 67-117, VCH
5. Weininger, D. (1988) J. Chem. Inf. Comput. Sci. 28, 31-36
6. Gund, P. (1977) in Progress in Molecular and Subcellular Biology, Vol. 5 (Hahn, F.E., ed.), pp 117-143, Springer-Verlag
7. Smellie, A., Teig, S.L. and Towbin, P. (1995) J. Comput. Chem. 16, 171-187
8. Sprague, P.W. (1991) in Recent Advances in Chemical Information - Proceedings of the 1991 Chemical Information Conference (Collier, H., ed.), pp. 107-111, Royal Society of Chemistry, Cambridge
9. Murral, N.W. and Davies, E.K. (1990) J. Chem. Inf. Comput. Sci. 30, 312-316
10. Hurst, T. (1994) J. Chem. Inf. Comput. Sci. 34, 190-196
11. Moock, T.E. et al. (1994) J. Chem. Inf. Comput. Sci. 34, 184-189
12. Wermuth, C-G. and Langer, T. (1993) in Drug Design: Theory, Methods and Applications (Kubinyi, H., ed.), pp. 117-136, ESCOM
13. Golender, V.E. and Vorpagel, E.R. (1993) in 3D QSAR in Drug Design: Theory, Methods and Applications (Kubinyi, H., ed.), pp. 137-149, ESCOM
14. Manallack, D.T. (1994) in Molecular Modelling and Drug Design (Vinter, J.G. and Gardner, M., eds), pp. 333-376, Macmillan Press
15. Scott, R.K., Hoffmann, R.D. and Manallack, D.T. (1995) paper presented at the SCI conference on the Design of Bioactive Compounds, September 1995, Potsdam (in preparation)
16. Ashton, M.J., Jaye, M.C. and Mason, J.S. (1996) Drug Discovery Today 1, 71-78
17. Erion, M.D. et al. (1993) J. Med. Chem. 36, 3771-3783
18. Kuntz, I.D. et al. (1982) J. Mol. Biol. 161, 269-288
19. Bodian, D.L. et al. (1993) Proteins 17, 266-276
20. Dejarlais, R.L. et al. (1990) Proc. Natl Acad. Sci. USA 87, 6644-6648
21. Rutenber, E. et al. (1993) J. Biol. Chem. 268, 15343-15346
22. Perry, N.C. and van Geerestein, V.J. (1992) J. Chem. Inf. Comput. Sci. 32, 607-616
23. Lauri, G. and Bartlett, P. (1994) J. Comput.-Aided Mol. Design 8, 51-66
24. Lowe, J.A. and Cheng, J.B. (1992) Drugs Future 17, 799-807
25. Stocker, W. et al. (1995) Protein Sci. 4, 823-840
26. Muller, K. (ed.) (1995) Perspect. Drug Design 3, issue dedicated to de novo drug design
27. Sadowski, J., Gasteiger, J. and Klebe, G. (1994) J. Comp. Inf. Comput. Sci. 34, 1000-1008